Xencor, Inc.
🏢 View company profile →215Patents
191Active
215Granted
55Portfolio score
Filing activity: Oct 15, 1999 → Aug 20, 2024 · 39 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7317091B2 | Optimized Fc variants | Chemistry; Metallurgy | 439 | Expired |
| US7662925B2 | Optimized Fc variants and methods for their generation | Chemistry; Metallurgy | 205 | Active |
| US8367805B2 | Fc variants with altered binding to FcRn | Emerging Cross-Sectional Technologies | 171 | Active |
| US8188231B2 | Optimized FC variants | Chemistry; Metallurgy | 161 | Active |
| US7276585B2 | Immunoglobulin variants outside the Fc region | Chemistry; Metallurgy | 148 | Expired |
| US6403312B1 | Protein design automatic for protein libraries | Chemistry; Metallurgy | 139 | Expired |
| US8637641B2 | Antibodies with modified isoelectric points | Chemistry; Metallurgy | 124 | Active |
| US7315786B2 | Protein design automation for protein libraries | Physics | 119 | Expired |
| US8063187B2 | Methods and compositions for inhibiting CD32B expressing cells | Chemistry; Metallurgy | 109 | Active |
| US8101720B2 | Immunoglobulin insertions, deletions and substitutions | Chemistry; Metallurgy | 92 | Active |
| US7657380B2 | Methods of generating variant antibodies with increased host string content | Physics | 85 | Expired |
| US8084582B2 | Optimized anti-CD20 monoclonal antibodies having Fc variants | Chemistry; Metallurgy | 76 | Active |
| US8088376B2 | Fc variants with altered binding to FcRn | Emerging Cross-Sectional Technologies | 72 | Active |
| US6514729B1 | Recombinant interferon-beta muteins | Human Necessities | 69 | Expired |
| US8802820B2 | Fc variants with altered binding to FcRn | Chemistry; Metallurgy | 68 | Active |
| US9856327B2 | Heterodimeric antibodies to CD3 X CD123 | Chemistry; Metallurgy | 64 | Active |
| US8039592B2 | Optimized Fc variants and methods for their generation | Physics | 57 | Active |
| US8388955B2 | Fc variants | Chemistry; Metallurgy | 53 | Active |
| US8329867B2 | CTLA4-Ig immunoadhesins | Chemistry; Metallurgy | 53 | Active |
| US8124731B2 | Optimized Fc variants and methods for their generation | Chemistry; Metallurgy | 50 | Active |
| US8735545B2 | Fc variants having increased affinity for fcyrllc | Chemistry; Metallurgy | 37 | Active |
| US8093359B2 | Optimized Fc variants and methods for their generation | Physics | 36 | Active |
| US7056695B2 | TNF-α variants | Human Necessities | 35 | Expired |
| US9605061B2 | Antibodies with modified isoelectric points | Chemistry; Metallurgy | 35 | Active |
| US8093357B2 | Optimized Fc variants and methods for their generation | Chemistry; Metallurgy | 34 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.